Tanya Wallace

Tanya Wallace has extensive work experience in the field of life sciences. Tanya is currently employed as the VP, Head of Translational Science at Neumora since October 2020. Prior to that, they worked as the Senior Director, Head of Biology at BlackThorn Therapeutics from November 2016 to September 2020. Tanya also served as a Senior Program Director at SRI International from December 2009 to November 2016. Before that, they worked as a Principal Research Scientist-Team Leader at Roche from December 2004 to November 2009. Tanya also has experience as a Senior Research Investigator at Bristol-Myers Squibb from September 2002 to September 2004, and as a member of the Division of Molecular Psychiatry at Yale University from April 2000 to September 2002. Tanya began their career as an intern at Procter & Gamble in 1995.

Tanya Wallace has a Bachelor of Science (B.S.) in Biology from The Ohio State University. Tanya also holds a Doctor of Philosophy (Ph.D.) in Neuroscience from the University of Cincinnati College of Medicine. Currently, Tanya is a Postdoctoral Fellow at Yale University School of Medicine, specializing in Molecular Psychiatry in the Laboratory of Ronald Duman, Ph.D.